T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow

J Exp Med. 2009 Oct 26;206(11):2469-81. doi: 10.1084/jem.20090525. Epub 2009 Oct 6.

Abstract

During a screen for ethylnitrosourea-induced mutations in mice affecting blood natural killer (NK) cells, we identified a strain, designated Duane, in which NK cells were reduced in blood and spleen but increased in lymph nodes (LNs) and bone marrow (BM). The accumulation of NK cells in LNs reflected a decreased ability to exit into lymph. This strain carries a point mutation within Tbx21 (T-bet), which generates a defective protein. Duane NK cells have a 30-fold deficiency in sphingosine-1-phosphate receptor 5 (S1P5) transcript levels, and S1P5-deficient mice exhibit an egress defect similar to Duane. Chromatin immunoprecipitation confirms binding of T-bet to the S1pr5 locus. S1P-deficient mice exhibit a more severe NK cell egress block, and the FTY720-sensitive S1P1 also plays a role in NK cell egress from LNs. S1P5 is not inhibited by CD69, a property that may facilitate trafficking of activated NK cells to effector sites. Finally, the accumulation of NK cells within BM of S1P-deficient mice was associated with reduced numbers in BM sinusoids, suggesting a role for S1P in BM egress. In summary, these findings identify S1P5 as a T-bet-induced gene that is required for NK cell egress from LNs and BM.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Marrow Cells / cytology*
  • Bone Marrow Cells / drug effects
  • Cell Count
  • Cell Movement* / drug effects
  • Ethylnitrosourea
  • Fingolimod Hydrochloride
  • Killer Cells, Natural / cytology*
  • Killer Cells, Natural / drug effects
  • Killer Cells, Natural / metabolism*
  • Lymph Nodes / cytology*
  • Lymph Nodes / drug effects
  • Lymphocyte Activation / drug effects
  • Lysophospholipids / deficiency
  • Lysophospholipids / pharmacology
  • Mice
  • Mice, Mutant Strains
  • Mutation / genetics
  • Propylene Glycols / pharmacology
  • Receptors, Lysosphingolipid / metabolism*
  • Sphingosine / analogs & derivatives
  • Sphingosine / deficiency
  • Sphingosine / pharmacology
  • T-Box Domain Proteins / metabolism*

Substances

  • Lysophospholipids
  • Propylene Glycols
  • Receptors, Lysosphingolipid
  • T-Box Domain Proteins
  • T-box transcription factor TBX21
  • sphingosine 1-phosphate
  • Fingolimod Hydrochloride
  • Sphingosine
  • Ethylnitrosourea